A Win For TransCode Therapeutics Inc.
Tue, Oct 24, 2023 at 07:16 PM
TransCode Therapeutics Inc. (RNAZ:NASDAQ) shot up at $0.43, representing a gain of 40.4%. On Tue, Oct 24, 2023, RNAZ:NASDAQ hit a New 2-Week Intraday High of $0.52. The stock got featured on our News Catalysts scanner on Tue, Oct 24, 2023 at 10:51 AM in the 'BIOTECH' category. From Tue, Oct 10, 2023, the stock recorded 22.22% Up Days and 20.00% Green Days
The stock spiked on Mon, Sep 25, 2023 at $3.2 with a volume of 97M+.
About TransCode Therapeutics Inc. (RNAZ:NASDAQ)
TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics.
Top 10 Gainers:
- LianBio (LIAN:NASDAQ), 117.27%
- Signature Bank (SBNY:NASDAQ), 81.82%
- Forbion European Acquisition Corp. (FRBN:NASDAQ), 72.84%
- InMed Pharmaceuticals Inc. (INM:NASDAQ), 70.53%
- TransCode Therapeutics Inc. (RNAZ:NASDAQ), 40.39%
- Mullen Automotive Inc. (MULN:NASDAQ), 36.73%
- Tharimmune Inc Com (THAR:NASDAQ), 34.07%
- Bridger Aerospace Group Holdings Inc. (BAER:NASDAQ), 32.27%
- Yoshiharu Global Co. (YOSH:NASDAQ), 30.36%
- Falcon's Beyond Global, Inc. (FBYD:NASDAQ), 30.25%